Brent L Wood Selected Research

Brent L Wood Research Topics

Disease

33	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 05/2010
28	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 08/2009
19	Residual Neoplasm 01/2020 - 05/2010
15	Neoplasms (Cancer) 01/2022 - 05/2002
12	Leukemia 10/2022 - 02/2008
12	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 05/2010
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 03/2011
5	Philadelphia Chromosome 10/2022 - 01/2017
5	Lymphoma (Lymphomas) 01/2022 - 05/2002
4	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2007
3	Multiple Myeloma 11/2019 - 02/2014
3	Hodgkin Disease (Hodgkin's Disease) 02/2017 - 11/2010
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2017 - 05/2002
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 09/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017 - 09/2008
1	Glucocorticoid Receptor Deficiency 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2018
1	Aneuploidy (Aneuploid) 02/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017
1	Macrocytic Anemia 11/2016
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 11/2016
1	Osteonecrosis (Kienbock's Disease) 10/2016
1	Juvenile Myelomonocytic Leukemia 01/2016
1	Splenomegaly 01/2016
1	Plasmacytoma 02/2014

Drug/Important Bio-Agent (IBA)

7	AntigensIBA 01/2019 - 09/2003
6	pegaspargase (Oncaspar)FDA Link 10/2021 - 07/2015
5	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 07/2015
5	Monoclonal AntibodiesIBA 01/2018 - 05/2002
4	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2007
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016 - 01/2013
3	blinatumomabIBA 10/2022 - 01/2017
3	Chimeric Antigen ReceptorsIBA 04/2022 - 09/2008
3	nelarabine (506U78)FDA Link 10/2020 - 07/2015
2	CytokinesIBA 01/2022 - 01/2020
2	GlucocorticoidsIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 02/2018
2	Leucovorin (Folinic Acid)FDA Link 10/2020 - 10/2018
2	Protein Isoforms (Isoforms)IBA 01/2020 - 04/2016
2	LigandsIBA 11/2019 - 02/2017
2	Transcription Factors (Transcription Factor)IBA 12/2018 - 08/2017
2	treosulfanIBA 01/2018 - 03/2011
2	fludarabineIBA 01/2018 - 03/2011
2	Clofarabine (Clolar)FDA Link 08/2015 - 04/2015
2	StreptavidinIBA 02/2014 - 02/2008
2	procaine isothiocyanate (PRIT)IBA 02/2014 - 02/2008
2	Biological ProductsIBA 01/2013 - 08/2010
2	lintuzumabIBA 01/2013 - 08/2009
2	ParaffinIBA 07/2012 - 05/2003
1	Proteasome InhibitorsIBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	SEC Translocation ChannelsIBA 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Interleukin-7 (Interleukin 7)IBA 01/2020
1	SteroidsIBA 01/2020
1	B-Cell Maturation AntigenIBA 11/2019
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 11/2019
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2019
1	Polycomb Repressive Complex 2IBA 12/2018
1	methylervineIBA 10/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	daratumumabIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 07/2017
1	B7-H1 AntigenIBA 02/2017
1	Immunoglobulin M (IgM)IBA 02/2017
1	Immunoglobulin D (IgD)IBA 02/2017
1	FenretinideIBA 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	RetinoidsIBA 01/2017
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2017
1	GlobinsIBA 11/2016
1	Heme (Haem)IBA 11/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2016
1	Fetal Hemoglobin (Hemoglobin F)IBA 01/2016
1	tosedostatIBA 01/2016
1	Decitabine FDA Link 01/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2015
1	4-O-carboxymethylascochlorinIBA 07/2014
1	Biotin (Vitamin H)FDA Link 02/2014
1	ADP-ribosyl Cyclase 1IBA 02/2014

Therapy/Procedure

30	Therapeutics 01/2022 - 05/2002
16	Cell Transplantation 10/2022 - 03/2011
16	Drug Therapy (Chemotherapy) 10/2022 - 05/2010
4	Transplantation 02/2016 - 05/2002
3	Radioimmunotherapy 02/2014 - 05/2002
2	Immunotherapy 01/2022 - 01/2018
2	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2019
2	Cranial Irradiation 10/2018 - 01/2018
2	Aftercare (After-Treatment) 05/2012 - 04/2008
1	Radiotherapy 12/2021
1	Consolidation Chemotherapy 12/2017
1	Remission Induction 01/2017
1	Homologous Transplantation 01/2016